Albemarle (ALB) Cash & Equivalents (2009 - 2026)

Albemarle has reported Cash & Equivalents for 18 years, with the latest figure at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 28.23% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 28.23% YoY), and the FY2025 full-year result was $1.6 billion, up 35.71% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $1.1 billion, down from $1.6 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $2.1 billion in Q1 2024, with the low at $463.3 million in Q1 2022.
• Historically, Cash & Equivalents has averaged $1.5 billion across 5 years, with a median of $1.6 billion in 2023.
• The largest YoY upside for Cash & Equivalents was 242.47% in 2023 against a maximum downside of 40.64% in 2023.
• Albemarle's Cash & Equivalents stood at $1.5 billion in 2022, then tumbled by 40.64% to $889.9 million in 2023, then soared by 33.97% to $1.2 billion in 2024, then surged by 35.71% to $1.6 billion in 2025, then slumped by 32.64% to $1.1 billion in 2026.
• The last three Cash & Equivalents figures came in at $1.1 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.